Technology News and Research

RSS

Johns Hopkins Medicine acquires Naviscan Positron Emission Mammography for radiotracer research

Johns Hopkins Medicine has become the latest academic medical center to acquire the Naviscan Positron Emission Mammography (PEM) scanner. The device will be utilized by Richard Wahl, M.D., F.A.C.R, Professor of Radiology and Nuclear Medicine at the Johns Hopkins University School of Medicine, in pre-clinical and translational research for the development of novel radiotracers.

18 Feb 2010

AltraVax acquires vaccine development technology package from Maxygen

AltraVax, Inc., a new, privately-held biopharmaceutical company, has acquired a vaccine development technology package from Maxygen, Inc. that gives AltraVax an exclusive license to develop vaccines for infectious diseases and is targeting influenza, a treatment for hepatitis B and HIV.

18 Feb 2010

CryoLife discloses financial results for fourth-quarter and full-year 2009

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that revenues for the fourth quarter of 2009 increased 12 percent to a quarterly record of $28.6 million compared to $25.5 million for the fourth quarter of 2008. This was the 12th consecutive quarter of profitability for the Company.

18 Feb 2010

Merge Healthcare passes interoperability tests at IHE Connectathon

As a part of its ongoing commitment to interoperability standards, Merge Healthcare, a leading health IT solutions provider, announced that it successfully passed interoperability tests at the Integrating the Healthcare Enterprise (IHE), North American Connectathon event in Chicago, Illinois. During the testing, which connects vendor solutions to promote better electronic information exchange, Merge demonstrated interoperability with every vendor pairing, which included some of the largest companies in the world.

18 Feb 2010

BIOGUARD wound dressings with Quick-Med’s NIMBUS antimicrobial technology to be sold by Medline Industries

Quick-Med Technologies, Inc. announced today that its licensee, Derma Sciences, Inc., has entered into an exclusive distribution agreement with Medline Industries whereby Medline will market and sell BIOGUARD™ wound dressings with Quick-Med’s proprietary NIMBUS antimicrobial technology. The agreement covers the acute care segment of the health care market, which includes nearly 6,000 hospitals in the United States plus surgery centers, wound care centers, and other associated health care facilities. Sales under this new agreement are expected to start later this month.

18 Feb 2010

Intezyne announces new patents covering IVECT Method in major pharmaceutical markets

Intezyne today announced the issuance of new patents that cover multiple dimensions of the Company’s revolutionary technology platform, the IVECTTM Method, in the major pharmaceutical markets of the United States, Europe, and Japan. All patents are wholly owned by Intezyne.

18 Feb 2010

Emtec to demonstrate thin client solution at HIMSS 2010 Conference and Exhibition

Emtec, Inc., a systems integrator, announced today that it will demonstrate its thin client solution for healthcare in the Avnet booth #7467 at the HIMSS 2010 Conference and Exhibition. This solution integrates the ThinIdentity™ virtual desktop infrastructure solution, smart card technology and stateless thin-client computing based on the Sun Microsystems™ Sun Ray virtual display client.

18 Feb 2010

Dow AgroSciences and the Victorian Government announce new research alliance

A new research alliance between the Victorian Government and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, will create 30 new Victorian agricultural biotech jobs, the Premier John Brumby announced this week.

18 Feb 2010

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

West Pharmaceutical Services, Inc. today announced its results for the fourth quarter and full year of 2009.

18 Feb 2010

IRA to offer Personal Genetic Health and Ancestry Testing to residents of Latin America

Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company today announced that the Instituto de Referencia Andino (IRA), a Clinical Laboratory and Division of Rochem Biocare will offer Personal Genetic Health and Ancestry Testing to residents of Latin America.

18 Feb 2010

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

On the first anniversary of the American Recovery and Reinvestment Act (ARRA) - the economic stimulus - the nation's research universities today provided nearly 100 examples of how a relatively small element of the measure is paying outsize short- and long-term dividends for the nation. Of the $787 billion contained in the ARRA, $21.5 billion is allocated for research and science infrastructure.

18 Feb 2010

AGBT meeting: Study workshop on complete genome sequencing for human disease

Complete Genomics Inc., a third-generation human genome sequencing company, today announced that it will be unveiling some of its highly anticipated customer results at the 11th annual Advances in Genome Biology and Technology (AGBT) meeting to be held in Marco Island, Fla., Feb. 24-27, 2010.

18 Feb 2010

Single microRNA exhibits potential to forecast outcomes of MPM

Rosetta Genomics, Ltd., a leading developer and provider of microRNA-based molecular diagnostics, announced today that the results of a joint study with the NYU Langone Medical Center were published online on February 16th, 2010, and are set to be published in the March 1st issue of the American Association for Cancer Research’s journal, Cancer Research.

18 Feb 2010

Biotage announces global launch of Syro Wave microwave and parallel peptide synthesizer

Biotage, a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.

18 Feb 2010

Clarion Care develops healthcare software solution to reduce deficit by 42%

As Washington state government considers difficult tax increases and searches for ways to cut spending, Clarion Care, an innovative company, has developed a healthcare software solution that can reduce the deficit by 42%.

18 Feb 2010

Easier walking for amputees: Artificial foot that recycles energy

An artificial foot that recycles energy otherwise wasted in between steps could make it easier for amputees to walk, its developers say.

18 Feb 2010

Nautic Partners completes recapitalization of HPS in partnership with management

Nautic Partners, LLC, a private equity firm with more than $2.5 billion of capital under management, today announced that it has completed a recapitalization of Healthcare Payment Specialists, LLC (“HPS”) in partnership with management. HPS is a provider of payment and reimbursement solutions to hospitals and other healthcare systems.

18 Feb 2010

Upp Technology adds Vaccine Provider Registration System to irms software suite

Upp Technology, a leader in public health software solutions, announced today at the Public Health Preparedness Summit, that it has enhanced its suite of irms software with the addition of the irms Vaccine Provider Registration System. The new provider management solution is already running in multiple states and the company expects to announce the deployment of this system in another four states within the first quarter of 2010.

18 Feb 2010

NCI's NCL to conduct characterization studies of Celator Pharmaceuticals' HDPN formulation

Celator Pharmaceuticals today announced that the National Cancer Institute's (NCI) Nanotechnology Characterization Laboratory (NCL), operated by SAIC-Frederick (Frederick, Maryland), has agreed to conduct characterization studies to advance the development of the company's nanoparticle drug formulation technology.

18 Feb 2010

Sorin Group's newest generation C5 HLM system receives FDA clearance

Sorin Group, a global company and a leader in the treatment of cardiovascular diseases, announced today the U.S. Food and Drug Administration (FDA) clearance of its newest generation C5 Heart-Lung Machine (HLM).

18 Feb 2010

Technology News and Research

Johns Hopkins Medicine acquires Naviscan Positron Emission Mammography for radiotracer research

AltraVax acquires vaccine development technology package from Maxygen

CryoLife discloses financial results for fourth-quarter and full-year 2009

Merge Healthcare passes interoperability tests at IHE Connectathon

BIOGUARD wound dressings with Quick-Med’s NIMBUS antimicrobial technology to be sold by Medline Industries

Intezyne announces new patents covering IVECT Method in major pharmaceutical markets

Emtec to demonstrate thin client solution at HIMSS 2010 Conference and Exhibition

Dow AgroSciences and the Victorian Government announce new research alliance

West Pharmaceutical Services reports 19.9% growth in consolidated fourth-quarter sales

IRA to offer Personal Genetic Health and Ancestry Testing to residents of Latin America

ScienceWorksForUS reveals how Recovery Act science funding benefits their campuses and communities

AGBT meeting: Study workshop on complete genome sequencing for human disease

Single microRNA exhibits potential to forecast outcomes of MPM

Biotage announces global launch of Syro Wave microwave and parallel peptide synthesizer

Clarion Care develops healthcare software solution to reduce deficit by 42%

Easier walking for amputees: Artificial foot that recycles energy

Nautic Partners completes recapitalization of HPS in partnership with management

Upp Technology adds Vaccine Provider Registration System to irms software suite

NCI's NCL to conduct characterization studies of Celator Pharmaceuticals' HDPN formulation

Sorin Group's newest generation C5 HLM system receives FDA clearance

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News